E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/16/2016 in the Prospect News Structured Products Daily.

HSBC set to price yield notes on Amgen, Biogen, Thermo Fisher shares

By Wendy Van Sickle

Columbus, Ohio, Dec. 16 – HSBC USA Inc. plans to price yield notes due December 2017 linked to the common stocks of Amgen Inc., Biogen Inc. or Thermo Fisher Scientific Inc., according to an FWP filing with the Securities and Exchange Commission.

The interest rate will be at least 8% per year and will be set at pricing. Interest will be payable quarterly.

The payout at maturity will be par unless the shares of any of the stocks finish below their trigger level, 65% of their initial levels, in which case investors will be fully exposed to the decline of the shares of the worst-performing stock from their initial level.

HSBC Securities (USA) Inc. is the agent.

The notes will price and settle in December.

The Cusip number is 40433UF76.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.